BioSante (BPAX) Downgraded by Numerous Analysts

BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) was downgraded by a variety of analysts.

BioSante Pharmaceuticals, Inc. (BPAX) was downgraded by McNicoll Lewis & Vlak to a “Hold” rating.

BioSante Pharmaceuticals, Inc. was downgraded by MLV & Co from a “Buy” rating to a “Hold” rating.

BioSante Pharmaceuticals, Inc. was downgraded by Roth Capital from a “Buy” rating to a “Neutral” rating.

BioSante Pharmaceuticals, Inc. was downgraded by Rodman & Renshaw from an “Outperform” rating to a “Market Perform” rating.

BioSante Pharmaceuticals, Inc. was downgraded by JMP Securities from an “Outperform” rating to a “Market Perform” rating.

BioSante Pharmaceuticals, Inc. was downgraded by Jefferies (NYSE:JEF) from a “Buy” rating to a “Hold” rating.

BioSante Pharmaceuticals, Inc. was downgraded by Leerink from an “Outperform” rating to a “Market Perform” rating.